crystalline compound, crystalline form of the compound, solid compound, methods for preparing the crystalline compound, for the manufacture of the compound and for the manufacture of a pharmaceutical composition of the compound, pharmaceutical composition, use of the crystalline compound, and methods of treating a neurodegenerative disease. and treating parkinson's badly

摘要

CRYSTALLINE COMPOUND, CRYSTALLINE FORM OF COMPOUND, SOLID COMPOUND, METHODS FOR PREPARING CRYSTALLINE COMPOUND, FOR MANUFACTURE OF COMPOUND, AND FOR MANUFACTURING COMPOSITION OF COMPOUND, PHARMACEUTICAL COMPARISON OF PHARMACEUTICAL, PHARMACEUTICAL COMPOSITION AND TREATMENT OF PARKINSON EVIL Described are the crystalline forms of the pharmaceutical compound "¢ 9S- (9 244, 10 225, 12 244) methyl acid ester! - 5,16-Bis ¢ (ethylthio) methyl -2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindole-1,2,2-fg: 3 ' , 2 ', 1'-K1-pyrrolo [3,4-i] [1,6] benzodiazocine-10-carboxylic acid "as well as the methods for their use and preparation.